share_log

微創醫療:授出購股權

MICROPORT: GRANT OF SHARE OPTIONS

香港交易所 ·  Apr 8 10:40
Summary by Moomoo AI
微創醫疗科學有限公司於2024年4月8日向46名合資格參與者授出總計11,648,808份購股權,該購股權可在10年有效期內行使,以認購相同數量的普通股,佔公司已發行股本約0.635%。授出的購股權行使價為每股6.58港元,與授出日期的收市價相同。該股份計劃旨在激勵員工和服務提供者,以促進公司業務發展和成功。其中,一名董事的家族成員作為服務提供者參與者,獲得的購股權獲全面豁免遵守上市規則相關規定。此外,根據現有計劃授權限額,公司尚有152,541,595股股份可供日後授出。微創醫療表示,此舉有助於吸引及挽留對公司長期增長作出重要貢獻的人才。
微創醫疗科學有限公司於2024年4月8日向46名合資格參與者授出總計11,648,808份購股權,該購股權可在10年有效期內行使,以認購相同數量的普通股,佔公司已發行股本約0.635%。授出的購股權行使價為每股6.58港元,與授出日期的收市價相同。該股份計劃旨在激勵員工和服務提供者,以促進公司業務發展和成功。其中,一名董事的家族成員作為服務提供者參與者,獲得的購股權獲全面豁免遵守上市規則相關規定。此外,根據現有計劃授權限額,公司尚有152,541,595股股份可供日後授出。微創醫療表示,此舉有助於吸引及挽留對公司長期增長作出重要貢獻的人才。
Micro-Chung Medical Sciences Limited granted a total of 11,648,808 share options to 46 eligible participants on 8 April 2024, which are exercisable for a period of 10 years to subscribe for the same number of ordinary shares representing approximately 0.635% of the Company's issued share capital. The exercise price of the warrants granted is HK$6.58 per share, the same as the closing price on the date of the grant. The share program aims to motivate employees and service providers to promote the development and success of the company's business. In this case, a director's family member, as a service provider participant, receives a full exemption from share rights in compliance with the relevant provisions of the Listing Rules. In addition, under the existing plan authorization limits, the Company still has 152,541,595 shares of common stock available for future issuance. Micro-Chao Medical said the move helps attract and retain talent who make an important contribution to the company's long-term growth.
Micro-Chung Medical Sciences Limited granted a total of 11,648,808 share options to 46 eligible participants on 8 April 2024, which are exercisable for a period of 10 years to subscribe for the same number of ordinary shares representing approximately 0.635% of the Company's issued share capital. The exercise price of the warrants granted is HK$6.58 per share, the same as the closing price on the date of the grant. The share program aims to motivate employees and service providers to promote the development and success of the company's business. In this case, a director's family member, as a service provider participant, receives a full exemption from share rights in compliance with the relevant provisions of the Listing Rules. In addition, under the existing plan authorization limits, the Company still has 152,541,595 shares of common stock available for future issuance. Micro-Chao Medical said the move helps attract and retain talent who make an important contribution to the company's long-term growth.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more